PRN logo

Invesco DWA Industrials Momentum ETF (PRN)

$257.78

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on PRN

AUM

$469167244

P/E ratio

33.8

Dividend yield

0.115%

Expense ratio

0.6%

Beta

1.278638

Price on PRN

Previous close

$252.23

Today's open

$258.18

Day's range

$255 - $261.01

52 week range

$152.54 - $262.73

Profile about PRN

show more

Headquarters

US

Exchange

NASDAQ Global Market

Issue type

Exchange-Traded Fund

PRN industries and sectors

Industries

Industrials

News on PRN

Should You Invest in the Invesco Dorsey Wright Industrials Momentum ETF (PRN)?

Launched on October 12, 2006, the Invesco Dorsey Wright Industrials Momentum ETF (PRN) is a passively managed exchange traded fund designed to provide a broad exposure to the Industrials - Broad segment of the equity market.

news source

Zacks Investment Research • Jun 15, 2026

news preview

Profound to Showcase TULSA-PRO®, the TULSA Procedure™ and the Future of iMRI at AUA2026

TORONTO, May 14, 2026 (GLOBE NEWSWIRE) --  Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets innovative interventional MRI (“iMRI”) procedures, is pleased to announce that the TULSA Procedure™ will be highlighted in four oral presentations at the upcoming American Urological Association's (“AUA”) Annual Meeting in Washington, DC, in the session titled “Prostate Cancer: Localized: Ablative Therapy II” on May 16th from 1:00-3:00 p.m. ET. TULSA Procedure Talks at AUA2026 Ram A.

news source

GlobeNewsWire • May 14, 2026

news preview

Industrials Momentum ETF (PRN) Touches a New 52-Week High

PRN hits a new 52-week high as momentum in industrial stocks accelerates, fueled by domestic manufacturing strength.

news source

Zacks Investment Research • May 7, 2026

news preview

Profound Medical Reports Strong First Quarter 2026 Financial Results

– Quarterly results marked by 104% revenue growth and improved operating performance – – Company issues full-year 2026 revenue guidance – – Announces Humana is now covering the TULSA Procedure™ – TORONTO, May 07, 2026 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets innovative interventional MRI (“iMRI”) procedures, today reported financial results for the first quarter ended March 31, 2026. Unless specified otherwise, all amounts in this press release are expressed in U.S. dollars and are presented in accordance with U.S. generally accepted accounting principles (U.S. GAAP).

news source

GlobeNewsWire • May 7, 2026

news preview

Global PMI: Tracking The Sectors Hit Hardest By The Middle East War

Survey data underscored how the war in the Middle East has already had a material impact on economic growth around the world. Drilling down deeper, the data showed weaker growth trends were recorded across all major industries globally.

news source

Seeking Alpha • Apr 12, 2026

news preview

PRN: Industrials Dashboard For March

All industrial subsectors are significantly overvalued, except transportation. The Invesco Dorsey Wright Industrials Momentum ETF offers superior fundamentals and historical returns versus the sector benchmark XLI. PRN is well-suited for long-term or tactical allocations, though XLI remains preferable for short-term traders due to superior liquidity.

news source

Seeking Alpha • Mar 17, 2026

news preview

Profound Medical Corp. (PRN:CA) Discusses First Clinical Outcomes and Precision of TULSA from the CAPTAIN Trial in Prostate Cancer Transcript

Profound Medical Corp. (PRN:CA) Discusses First Clinical Outcomes and Precision of TULSA from the CAPTAIN Trial in Prostate Cancer Transcript

news source

Seeking Alpha • Mar 13, 2026

news preview

Profound Medical Corp. (PRN:CA) Q4 2025 Earnings Call Transcript

Profound Medical Corp. (PRN:CA) Q4 2025 Earnings Call Transcript

news source

Seeking Alpha • Mar 6, 2026

news preview

Profound Medical Corp. (PRN:CA) Q3 2025 Earnings Call Transcript

Profound Medical Corp. ( PRN:CA ) Q3 2025 Earnings Call November 13, 2025 4:30 PM EST Company Participants Stephen Kilmer - Investor Relations Rashed Dewan Mathieu Burtnyk - President Thomas Tamberrino - Chief Commercial Officer Arun Menawat - Chairman of the Board & CEO Conference Call Participants Benjamin Haynor - Lake Street Capital Markets, LLC, Research Division John McAulay - Stifel, Nicolaus & Company, Incorporated, Research Division Michael Freeman - Raymond James Ltd., Research Division Presentation Operator Good day, and thank you for standing by.

news source

Seeking Alpha • Nov 14, 2025

news preview

Profound Medical Corp. (PROF) Q2 2025 Earnings Call Transcript

Profound Medical Corp. (NASDAQ:PROF ) Q2 2025 Earnings Conference Call August 14, 2025 4:30 PM ET Company Participants Arun Swarup Menawat - Chairman of the Board & CEO Mathieu Burtnyk - President Rashed Dewan - Chief Financial Officer Stephen Kilmer - Corporate Participant Investor Relations - Corporate Participant Thomas Tamberrino - Chief Commercial Officer Conference Call Participants Benjamin Charles Haynor - Lake Street Capital Markets, LLC, Research Division Douglas W. Loe - Leede Financial Inc., Research Division John Glenn McAulay - Stifel, Nicolaus & Company, Incorporated, Research Division Michael W.

news source

Seeking Alpha • Aug 15, 2025

news preview

¹ Disclosures

Get started with M1

Invest in Invesco DWA Industrials Momentum ETF

Open an M1 investment account to buy and sell Invesco DWA Industrials Momentum ETF commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in PRN on M1